Results 121 to 130 of about 10,275,652 (198)

Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma. [PDF]

Clin Cancer Res
Wiggins JM, Zhang Q, Zhang Y, Vand-Rajabpour F, Hanniford D, He L, Lu Y, Kenney JM, Sadeghi KD, Argibay D, Orlow I, Busam KJ, Lezcano C, Lee TK, Luo L, Gorlov IP, Amos C, Ernstoff MS, Seshan VE, Cust AE, Wilmott J, Scolyer RA, Mann GJ, Reiner A, Kostrzewa CE, Nagore E, Funchain P, Ko J, Edmiston SN, Conway K, Googe PB, Ollila DW, Lee JE, Rees JR, Thompson CL, Gerstenblith M, Bosenberg M, Gould Rothberg BE, Osman I, Saenger Y, Reynolds AZ, Boyce T, Holmen S, Yan S, Brunsgaard E, Bogner P, Kuan PF, Thomas NE, Begg CB, Shen R, Berwick M, Shao Y, Polsky D, Hernando E.   +53 more
europepmc   +1 more source

Efficacy and safety of almonertinib as adjuvant therapy in stage II-IIIA EGFR-mutant non-small cell lung cancer: a retrospective study. [PDF]

Front Med (Lausanne)
Cao T, Chen L, Li Y, Wu S, Liu Y, Tian W, Zhang Y, An Y, Wang M, Lu Z, Wang Q.   +10 more
europepmc   +1 more source

Sarcoidosis stage II

, 2020
openaire   +1 more source

Clear Aligner Therapy in Adults With Stage II-IV Periodontitis: A Narrative Review. [PDF]

Cureus
Kumari S, Gothankar G, Kv N, Rai S, Rana SS, Dixit A.   +5 more
europepmc   +1 more source

Structured physical activity in high-risk stage II and stage III colon cancer: tertiary prevention of colorectal cancer recurrence or primary prevention in a population at high risk of secondary cancers? [PDF]

ESMO Open
Moretto R, Conca V, Blondeaux E, Cremolini C.   +3 more
europepmc   +1 more source

Survival prediction in stage II/III rectal cancer: Role of immune-inflammatory biomarkers post neoadjuvant chemoradiotherapy. [PDF]

Oncol Lett
Li B, Huang T, Xu S, Ye Y, Liu Y, Wang X, Wang Y.   +6 more
europepmc   +1 more source

Nintedanib in the prevention of radiation-induced lung injury in patients with unresectable stage II-III NSCLC: A protocol for a randomized, multicenter, control group study. [PDF]

PLoS One
Cui A, Shi A, Deng L, Sun Y, Yu J, Lian X, Zhao Z.   +6 more
europepmc   +1 more source

Genetic landscape of stage II melanoma identifies CBL as a new driver gene and prognostic biomarker. [PDF]

Br J Cancer
Lindner ES, Admard J, Demidov G, Armeanu-Ebinger S, Sinnberg T, Niessner H, Amaral T, Garbe C, Forschner A, Kelemen O, Hilke FJ, Bonzheim I, Röcken M, Rieß O, Ossowski S, Schroeder C.   +15 more
europepmc   +1 more source

Cost-effectiveness of neoadjuvant and adjuvant novel cancer therapies in stage II-III non-small cell lung cancer in Sri Lanka. [PDF]

BMJ Oncol
Joseph N, Kularatna S, Senanayake S.
europepmc   +1 more source

Association of Metastatic Lymph Node Count and Primary Tumor Size with Disease-Free Survival in Stage II-III Gastric Cancer: A Retrospective Cohort Study. [PDF]

Medicina (Kaunas)
Kanatsız E, Sezgin Y, Yılmaz Ürün Y.
europepmc   +1 more source